Latest news

Erin Sharoni

26th June 2023

is a Master of Bioethics graduate student at Harvard Medical School (HMS) Center for Bioethics. She is a member of the Harvard Animal Law Society and serves on the leadership team of the Harvard GSAS Biotechnology Club, where she pursues policy and technology that advance the status of animals. Erin’s academic work at HMS focuses on the moral obligation to bear witness to animal suffering in agriculture and scientific research, and the ethical imperative to pursue microphysiological systems (e.g., organ chips) and artificial intelligence (AI) models to replace animal use in research. She is currently a researcher for the National Institutes of Health’s Bridge To Artificial Intelligence program, where she focuses on the ethical application of AI in precision medicine. Erin’s professional work in the biotechnology sector sits at the intersection of longevity, epigenetics, and AI, and leverages her academic pursuit of animal-free technology; she is currently working on AI technology that predicts Alzheimer’s Disease up to a decade prior to onset in asymptomatic individuals. Her notable publications include “Longitudinal analysis of biomarker data from a personalized nutrition platform in healthy subjects” (Scientific Reports, 2017) and “Good Research Relies on Reflexivity” (Impact Ethics, 2022). In opposition to controversial deprivation experiments on infant primates and their mothers at HMS, Erin published a widely-read opinion editorial in The Harvard Crimson, “There’s Nothing Ethical About Experimenting On Monkeys” (April, 2023). Erin holds a Master’s in the field of Biology from Harvard University DCE and a Bachelor’s with honors in Studio Art from Wesleyan University.